EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

Risk Factors for Microscopic Colitis: A Systematic Review and Meta‐Analysis

Anett Rancz iD, Brigitta Teutsch iD, Mahmoud Obeidat iD, Anna Walter, Gergő Weidinger, Bálint Erőss iD, Péter Hegyi iD, Emese Mihály iD

Journal of Gastroenterology and Hepatology · 2025-09 · 40 (9) · 2148-2162

DOI: 10.1111/jgh.70007 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 17.07.2025. Verfasst von Anett Rancz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Translational Medicine, Semmelweis University, Budapest, Hungary. Hauptthemen laut MEDLINE: Colitis, Microscopic, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry for Innovation and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Microscopic colitis (MC) is still an underdiagnosed disease due to its primarily histological appearance. We aimed to address the scarcity and inconsistency of data on MC risk factors.

Methods

Our protocol was prospectively registered in PROSPERO (CRD42022286624). We systematically searched PubMed, Embase, and Cochrane from inception to January 6, 2025. Cohort, case–control, and cross‐sectional studies were included. Controls were distinguished with or without a histopathological examination. We used the random‐effect model to calculate pooled odds ratios (ORs) with 95% confidence intervals (CIs).

Results

The systematic search yielded 6493 articles, of which 45 were meta‐analyzed. We found increased odds for MC in the case of nonsteroidal anti‐inflammatory drug (NSAID) and statin use compared to histological (OR = 2.57, CI: 1.45–4.53; OR = 2.15, CI: 1.14–4.05) and random (OR = 2.56, CI: 1.13–5.79; OR = 1.84, CI: 0.58–5.80) controls. Our results did not show an association between proton pump inhibitors (PPIs) and MC, compared to histological controls (OR = 1.81, CI: 0.75–4.35), except in the case of random controls (OR = 4.31, CI: 1.66–11.20). Neither current (OR = 1.35, CI: 0.88–2.06) nor previous smoking (OR = 1.26, CI: 0.67–2.39) increased the odds of MC compared to histological controls. In contrast, the odds doubled for current smoking and slightly changed for past smoking when MC patients were compared to random controls (OR = 2.40, CI: 1.64–3.50; OR = 1.11, CI: 0.93–1.31).

Conclusions

NSAID and statin treatment were associated with an increased risk for MC compared to histological controls. PPIs and smoking showed only an association with MC when random controls were used.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, MicroscopicAnti-Inflammatory Agents, Non-SteroidalHumansRisk FactorsHydroxymethylglutaryl-CoA Reductase InhibitorsProton Pump InhibitorsSmokingMaleFemale

Stichwörter der Autor:innen

MCNSAIDsPPIshistological controlsmicroscopic colitissmoking

Substanzen

Anti-Inflammatory Agents, Non-SteroidalHydroxymethylglutaryl-CoA Reductase InhibitorsProton Pump Inhibitors

Autor:innen und Institutionen

  • Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.
  • Department of Internal Medicine and Haematology, Semmelweis University, Medical School, Budapest, Hungary.
  • Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
  • Department of Radiology, Medical Imaging Centre, Semmelweis University, Budapest, Hungary.
  • Faculty of Medicine, Semmelweis University, Budapest, Hungary.
  • Institute of Pancreatic Diseases, Semmelweis University, Budapest, Hungary.

ORCID-Profile: Anett Rancz, Brigitta Teutsch, Mahmoud Obeidat, Bálint Erőss, Péter Hegyi, Emese Mihály

Förderung

  • Ministry for Innovation and Technology

Zitieren

APA

Rancz, A., Teutsch, B., Obeidat, M., Walter, A., Weidinger, G., Erőss, B., Hegyi, P., & Mihály, E. (2025). Risk Factors for Microscopic Colitis: A Systematic Review and Meta‐Analysis. Journal of Gastroenterology and Hepatology, 40(9), 2148-2162. https://doi.org/10.1111/jgh.70007

Vancouver

Rancz A, Teutsch B, Obeidat M, Walter A, Weidinger G, Erőss B, et al. Risk Factors for Microscopic Colitis: A Systematic Review and Meta‐Analysis. Journal of Gastroenterology and Hepatology. 2025;40(9):2148-2162. doi:10.1111/jgh.70007

BibTeX
@article{Rancz2025,
  author = {Rancz, Anett and Teutsch, Brigitta and Obeidat, Mahmoud and Walter, Anna and Weidinger, Gergő and Erőss, Bálint and Hegyi, Péter and Mihály, Emese},
  title = {Risk Factors for Microscopic Colitis: A Systematic Review and Meta‐Analysis},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2025},
  volume = {40},
  number = {9},
  pages = {2148--2162},
  doi = {10.1111/jgh.70007}
}
Kostenlos starten →